|
February 2008
Dr. Buckingham was featured on FOX 7 news morning show on February 27th. Dr. Buckingham was invited to be a guest after performing a nasal reconstruction following skin cancer excision for a local news celebrity. Dr. Susan Dozier, dermatologist, and Dr. Buckingham presented valuable information to the public about skin cancer screening, treatment and repair. You can visit FOX News website for the complete story.
http://www.myfoxaustin.com/myfox/pages/News/Detail?contentId=5891597&version=1&locale=EN-US&layoutCode=VSTY&pageId=3.5.1
The Buckingham Center for Facial Plastic Surgery is proud to be one of the first providers in Central Texas of GFX. GFX is a revolutionary new treatment utilizing bipolar radio frequency (RF) technology to target motor nerves, (nerves that initiate muscle action). This treatment ablates the nerve, causing the unwanted furrows to disappear. This Bipolar Radio Frequency technology has been used in lifesaving cardiology treatments for over 10 years. GFX uses a patent pending combination of technologies to precisely locate bodily structures, and then apply therapeutic energy. A low intensity stimulator allows us to precisely locate the structure for treatment. Following location, a specific dose of RF energy is applied to effectively ablate a portion of the targeted structure. The result is similar to BOTOX, but more permanent.
Dr. Buckingham has been invited to be an examiner for the American Board of Facial Plastic and Reconstructive Surgery in Washington, D.C. Dr. Buckingham sits on the examination development committee for the oral and written examinations of the Board. He feels that board certification and the maintenance of the board certification process are integral elements in physician training and measurement of performance.
January 2008
Dr. Buckingham recently returned from Vail Colorado and the Winter meeting of the American Academy of Facial Plastic and Reconstructive Surgery. The meeting is attended by specialists in cosmetic and reconstructive surgery from different disciplines. Dr. Buckingham delivered presentations on the topics of Autologous Fat Transfer and Nasal Reconstruction. Both talks were well received and generated much interest and inquiries regarding Dr. Buckingham’s expertise in both areas. Dr. Buckingham is a regular attendee of national and international meetings and is a regular speaker. He feels that participating in frequent meetings as an attendee and speaker keeps the Buckingham Center at the forefront of facial plastic and reconstructive surgeries.
November 2007
Dr. Buckingham has been invited to be on faculty for the Winter meeting of the American Academy of Facial Plastic and Reconstructive Surgery. Dr. Buckingham has been asked to speak about nasal reconstruction and cosmetic rejuvination of the periorbital area. As a recongnized expert in these areas, Dr. Buckingham will share his techniques with many other attendees as well as attend the meeting as a participant to continue to gather information about the newest most effective techniques in facial surgery.
November 2007
Dr. Buckingham recently attended the interim meeting of the American Medical Association. Dr. Buckingham is a delagate to the YPS section of the AMA representing the Texas Delegation. The AMA is intimately involved in assuring that governmental action takes place to constantly improve the health care for Americans. It is a constant process.
September 2007
Dr. Buckingham and his staff attend the annual fall meeting of The American Academy of Facial Plastic and Reconstructive Surgery in Washington. D.C. The meeting is held annually in the U.S. and Canada to encourage the sharing of the newest information regarding facial cosmetic and reconstructive surgery. The meeting is attended by the facial plastic surgeons from around the globe and is the most significant meeting in the world for facial plastic knowledge exchange.
June 22, 2007
Dr. Buckingham is scheduled to be available as an examiner for the American Board of Facial Plastic and Reconstructive Surgery exam in Washington, D.C. Each June, the ABFPRS administers the examination to eligible candidates. Dr. Buckingham additionally writes both written and oral questions for the ABFPRS exam.
May 4, 2007
The FDA has approved a new wrinkle filler called Perlane for the treatment of moderate to severe facial folds and wrinkles. Perlane is made by Medicis, which also makes the wrinkle filler Restylane. Both products contain hyaluronic acid. The primary difference between Restylane and Perlane is that the hyaluronic acid gel particles in Perlane are larger than those found in Restylane," says Medicis in a May 2 news release announcing the drug's approval. Medicis says Perlane's larger gel particles can reach the deep layers of the skin, offering "enhanced volume and lifting power." "Perlane has been used safely by dermatologists and plastic surgeons since 2000 outside the U.S.," says Medicis.
January 19, 2007
Dr. Buckingham presents his technique for endoscopic forehead and brow rejuvenation at the American Academy of Facial Plastic and Reconstructive Surgery Winter Meeting in Vail, CO. Dr. Buckingham spoke to an audience of Facial Plastic Surgeon, Oculoplastic Surgeons and Dermatologists about his philosophy of forehead rejuvenation including endoscopic forehead lifting and fat transfer.
October 30, 2006
Artes Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, today announced the United States Food and Drug Administration’s approval of ArteFill®. ArteFill is the first and only non-resorbable aesthetic injectable implant approved by the FDA. The product is indicated for the correction of facial wrinkles known as nasolabial folds, or smile lines. Unlike existing dermal fillers that are completely metabolized by the body, ArteFill represents the first product in a new category of non-resorbable dermal fillers providing a permanent support structure for enduring wrinkle correction.
|
|
|
